T1	Participants 123 166	patients with common cancers involving bone
T2	Participants 0 67	Bisphosphonate infusions: patient preference, safety and clinic use
T3	Participants 476 515	Enrolled in the study were 184 patients
T4	Participants 665 758	patients were randomized to receive Z then P or P then Z, and questioned on their preferences
T5	Participants 1370 1428	12% of eligible patients (16/138) received home infusions,
T6	Participants 1433 1473	13/14 questioned preferred this location
